Simplicity Wealth’s Regeneron Pharmaceuticals REGN Stock Holding History

Simplicity Wealth’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$732K	Buy	1,173 +226	+24%	+$154K	0.02%	523
2026 Q1	$731K	Buy	947 +102	+12%	+$78.1K	0.04%	363
2025 Q4	$653K	Buy	845 +467	+124%	+$317K	0.04%	369
2025 Q3	$213K	Buy	+378	New	+$214K	0.01%	665
2025 Q2	–	Sell	-331	Closed	-$210K	–	649
2025 Q1	$210K	Buy	+331	New	+$228K	0.02%	517
2024 Q3	–	Sell	-14,060	Closed	-$14.8M	–	1045
2024 Q2	$14.8M	Sell	14,060 -753	-5%	-$730K	0.33%	53
2024 Q1	$14.3M	Buy	+14,813	New	+$14.1M	0.34%	53

Other funds holding REGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Swiss National Bank Zurich, Switzerland $191B AUM 45.21% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Simplicity Wealth's REGN Position: Q2 2026 in Review

Simplicity Wealth increased its Regeneron Pharmaceuticals (REGN) stake by 24% in Q2 2026, buying an estimated $154K and bringing the position to 1,173 shares worth $732K. The position accounts for 0.02% of the portfolio, ranked #523.

Simplicity Wealth first reported a position in REGN in Q1 2024 and has held it in 7 quarters since. The position peaked at $14.8M in Q2 2024. 792 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

Simplicity Wealth held 1,173 shares of Regeneron Pharmaceuticals worth $732K as of Q2 2026.
Simplicity Wealth bought 226 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $154K.
Regeneron Pharmaceuticals made up 0.02% of Simplicity Wealth's portfolio in Q2 2026, its #523 holding.
Simplicity Wealth first reported a position in Regeneron Pharmaceuticals in Q1 2024 and has held it in 7 quarters since.
Simplicity Wealth's Regeneron Pharmaceuticals position peaked at $14.8M in Q2 2024.
792 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Simplicity Wealth's 13F filing for Q2 2026, filed 6 Aug 2026.